On Wednesday, Shares of Copart, Inc. (NASDAQ:CPRT), gained 0.31% to $35.32.
Copart, declared that it will release earnings for the fourth quarter of fiscal 2015 after the close of market on Tuesday, September 22, 2015.
On Wednesday, September 23, 2015, a conference call will be held at 11:00 a.m. Eastern Time (10:00 a.m. Central) to discuss the results and answer questions regarding the company’s performance for the quarter ended July 31, 2015.
Copart, Inc. provides online auctions and vehicle remarketing services. The company offers a range of services for processing and selling vehicles over the Internet through its Virtual Bidding Third Generation Internet auction-style sales technology to vehicle sellers, primarily insurance companies, banks and financial institutions, charities, car dealerships, fleet operators, and vehicle rental companies.
Shares of WaferGen Bio-systems, Inc. (NASDAQ:WGBS), declined -6.25% to $1.65, during its last trading session.
WaferGen Bio-systems, presented results from its Single-Cell System at the Single Cell Genomics Conference in Utrecht, The Netherlands. The poster presentation comprised results from early access collaborators at The University of Texas MD Anderson Cancer Center. The landmark results demonstrated the ability of WaferGen’s Single-Cell System to isolate thousands of single cells and process specific cells of interest for downstream analysis using Next Generation Sequencing (NGS).
The results demonstrated that WaferGen’s Single-Cell system can compriseently isolate up to 1,800 single cells per chip and also identify and process individual cells using its automated image analysis software. The Single-Cell system was shown to be capable of isolating various cell types, counting mixtures of K562, U-87 MG, Z138 and Hela cells in experiments designed to mimic the heterogeneous cell types present in complex samples. In additional experiments where two cell types were mixed to contain about 1% of one of the cell types, the Single-Cell System was able to unambiguously identify wells that contained each cell type as evidenced by the analysis of NGS data from ~100,000 sequencing reads per cell.
Data presented in early access experiments performed at Dr. Nicholas Navin’s laboratory at MD Anderson Cancer Center showed that over a thousand SKBR3 cells (a triple negative breast cancer cell line), in addition to nuclei isolated from these cells, can be isolated and dispensed. In additional early access experiments highlighted at the conference, the WaferGen Single-Cell System was capable of isolating and selecting over 13,000 single cells in less than 8 hours using the system’s automated dispensing and image analysis software.
WaferGen Bio-systems, Inc. develops, manufactures, and sells systems for gene expression quantification, genotyping, and stem cell research for the life sciences and pharmaceutical drug discovery industries in the United States, Canada, Europe, and the Asia Pacific.
At the end of Wednesday’s trade, Shares of Brady Corp (NYSE:BRC), gained 4.03% to $20.90.
Brady Corporation, stated its financial results for its fiscal 2015 fourth quarter and year ended July 31, 2015.
Quarter Ended July 31, 2015 Financial Results:
Sales for the quarter ended July 31, 2015 reduced 8.9 percent to $288.6 million contrast to $316.7 million in the fourth quarter of fiscal 2014. Total organic sales reduced 1.2 percent and foreign currency translation reduced sales by 7.7 percent. By segment, organic sales reduced 0.3 percent in Identification Solutions and reduced 3.2 percent in Workplace Safety.
During the fourth quarter ended July 31, 2015, the Company recorded an impairment charge of $46.9 million primarily related to the write down of intangible assets in the Company’s Workplace Safety segment. These impairment charges were primarily driven by sales and profitability reductions and reduced forecasts for future sales and profitability growth. In the fourth quarter of last year, the Company also incurred an impairment charge of $148.6 million related to its PeopleID reporting unit.
The Company’s loss from ongoing operations for the quarter ended July 31, 2015 was $(39.4) million contrast to a loss of $(97.0) million in the same quarter of last year. Non-GAAP earnings from ongoing operations for the current quarter were $14.4 million contrast to $21.0 million in the fourth quarter of fiscal 2014.
The Company’s loss from ongoing operations per diluted Class A Nonvoting Common Share was $(0.77) for the quarter ended July 31, 2015 contrast to a loss of $(1.89) in the same quarter last year. Non-GAAP earnings from ongoing operations per diluted Class A Nonvoting Common Share* for the current quarter were $0.28 contrast to earnings of $0.41 per share in the fourth quarter of fiscal 2014.
Brady Corporation manufactures and supplies identification solutions, specialty materials, and workplace safety products that identify and protect premises, products, and people in the United States and internationally. It operates through two segments, Identification Solutions and Workplace Safety.
Finally, Semtech Corporation (NASDAQ:SMTC), ended its last trade with 0.29% gain, and closed at $17.22.
Semtech Corporation, will demonstrate the hybrid interoperability of its 12G UHD-SDI product portfolio by transporting ultra-high definition video over an integrated SDI and IP network at the International Broadcasting Convention (IBC) exhibition in Amsterdam on September 10-15, stand 10.F46.
The demonstration features a multi-format SDI/IP media gateway from Nevion, a leader in media transport solutions, a commercial off-the-shelf (COTS) 10Gbe / 40GbE IP switch and Semtech’s 12G UHD-SDI products—the GS12141 cable equalizer and the GS12181 cable driver. Semtech gearbox technology will be integrated to enable seamless conversion between different UHD-SDI interface profiles.
“Our UHD-SDI interoperability demonstration with Nevion’s VS902 illustrates the realization of a fully uncompressed hybrid SDI / IP infrastructure for UHD-1 production and contribution,” said John Hudson, Director of Planned Technology and New Business Development for Semtech’s Signal Integrity Product Group. “Nevion is a leader in hybrid media transport solutions, and the VS902 is a class-leading product that interoperates with Semtech’s entire portfolio of UHD-SDI products.”
Semtech Corporation designs, develops, manufactures, and markets analog and mixed-signal semiconductor products. The company provides protection products comprising filter and termination devices that are integrated with the transient voltage suppressor devices, which protect electronic systems from voltage spikes; power products, counting switching voltage regulators, combination switching and linear regulators, smart regulators, and charge pumps that control, alter, regulate, and condition the power within electronic systems; and discrete semiconductor products compriseing of rectifiers, assemblies, and other products for use in industrial, military, medical, automotive, and aerospace applications, in addition to defense systems, counting satellite communications.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
